Anti-pentraxin-3 antibodies were found in nearly 40% of cases with MPA, GPA or EGPA; approximately 35% of both MPO and PR3 ANCA-positive individuals and half of AAV cases without MPO or PR3 ANCA at diagnosis [43]. This evidence concerns the gene MPO and anti-neutrophil cytoplasmic antibody-associated vasculitis.